Hot Up And Coming Stocks To Invest In Right Now

Hot Up And Coming Stocks To Invest In Right Now: Cynosure Inc.(CYNO)

Cynosure, Inc. develops, manufactures, and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. Its aesthetic treatment systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag, and diode lasers, as well as intense pulsed light. The company?s aesthetic treatment systems comprise the Elite product line for hair removal, treatment of facial, and leg veins and pigmentations; the Smartlipo product line for LaserBodySculpting for the removal of unwanted fat; the Cellulaze, SmoothShapes XV, and TriActive product line for the temporary and long-term reduction in the appearance of cellulite; the Affirm/SmartSkin product line for anti-aging applications, such as treatments for wrinkles, skin texture, skin discoloration, and skin tightening; the Cynergy product line for the treatment of vascular lesions; and the Accolade product line for the removal of benign pigmented lesion s, as well as multi-colored tattoos. It sells its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Korea, China, Japan, and Mexico; and through international distributors in 84 other countries. Cynosure, Inc. was founded in 1991 and is based in Westford, Massachusetts.

Advisors' Opinion:

• [By John Udovich]

  Large cap serial acquirerValeant Pharmaceuticals International Inc (NYSE: VRX) is teaming up with activist investorBill Ackman to pursue large cap Botox maker Allergan, Inc (NYSE: AGN), but stocks like Cutera, Inc (NASDAQ: CUTR), Cynosure, Inc (NASDAQ: CYNO), PhotoMedex Inc (NASDAQ: PHMD) and Syneron Medical Ltd (NASDAQ: ELOS)actually offer investors more exposure to the growing anti aging and aesthetics market (Note: See my recent article: These Small Caps Seek to Treat Your Crows Feet and Double Chin (RVNC & KYTH)). To begin with, Valeant Pharmaceuticals Internat! ional has a wide focus on neurology, dermatology and infectious diseasesbut acquiring the maker of Botox wont be its first foray into the aesthetic marketbecause earlier this year, the company completed its acquisition of Solta Medical Inc (NASDAQ: SLTM) -a designer, developer, manufacturer and marketer ofenergy-based medical device systems for aesthetic applications.And whileAllergan, Inc may be most well known for Botox, its actually a pretty bigcompany focused on a diverse range of areas, including ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics meaning the following stocks offer investors better exposure to the aesthetics market:

• [By John Udovich]

  On Tuesday, small cap biotech stock Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) surged around 25% after announcing that its ATX-101 REFINE-1 and REFINE-2 Phase III trials met all primary and secondary endpoints for the reduction of so-called double chins; but if investors missed out on that rally, small caps Zeltiq Aesthetics Inc (NASDAQ: ZLTQ), Solta Medical Inc (NASDAQ: SLTM) and Cynosure, Inc (NASDAQ: CYNO) each have a piece of the aesthetic market as well. In the case of Kythera Biopharmaceuticals, its ATX-101 can be injected to deal with double chins meaning its less invasive than liposuction as the drug dissolves fat cells but leaves other tissue alone. JP Morgan has noted:

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/hot-up-and-coming-stocks-to-invest-in-right-now-3.html